Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECHO-1: injectable contraceptives versus Copper 380 IUD after pregnancy termination
PACTR201409000880157Completed
- Sponsor
- Effective Care Research Unit
- Start
- Jul 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of medroxyprogesterone acetate and norethisterone enanthate in unintended pregnancy (2 arms), sponsored by Effective Care Research Unit. Primary endpoint: unplanned pregnancy. Started Jul 2009; status: completed.
02
Drugs
medroxyprogesterone acetatenorethisterone enanthate
03
Conditions
unintended pregnancy
Beyond the preview
Go deeper on PACTR201409000880157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201409000880157.